Exp Opin Invest Drugs 1999
Safety Profile Retatrutides safety profile is comparable to other drugs in its class
Subscribe for free and join 4,200 other investors to make sure you dont miss our next briefing: A quick update on our buy recommendations before we jump in The Trade Desk: Just joined the S&P 500 and is up 18% vs 4.5% for the S&P 500 ASML Holding: ASML had an earnings beat, but is down 6% due to weak guidance AMD: Got approval to sell chips to China and is up 11% vs -0.3% for the S&P 500 As always, here is our complete tracker in one place
Injection site reactions, such as redness, swelling, itching, and discomfort, are insignificant side effects of Ipamorelin administration
Retatrutide pros Triple mechanism of action : Retatrutide targets GLP-1, GIP, and GCG, which could offer a more comprehensive approach to weight loss, blood sugar control, and metabolic health, potentially providing superior benefits over dual agonists like tirzepatide